Press releases

Professor Thierry De Baere to Join the Scientific Advisory Board of Quantum Surgical

Published on
May 17, 2021
Press Contact

Montpellier, France, May 17, 2021 - QuantumSurgical, an innovative medical robotic company, announced today the expansionof its Scientific Advisory Board (SAB) with the appointment of Pr. Thierry de Baere, Head of the Therapeutic Imaging Department atGustave Roussy, first cancer center in Europe.

The Quantum Surgical SAB is amulti-disciplinary board composed of international experts in the field ofimage-guided interventional oncology:

• Professor Steven D. Colquhoun (US), Liver transplant surgeon,specialized in robotic surgery at Cedars-Sinai Medical Center (Los Angeles, CA).

• Professor Thierry De Baere (FR), Head of theTherapeutic Imaging Department at Gustave Roussy Cancer Center (Villejuif).

• Professor Boris Guiu (FR), InterventionalRadiologist, Head of St Eloi Department of Diagnostic and InterventionalRadiology at Montpellier University Hospital (Montpellier).

• Professor Nishita Kothary (US), InterventionalRadiologist at Stanford University Medical Center (Stanford, CA).

• Professor David C. Madoff (US), InterventionalRadiologist at Yale New Haven Hospital (New Haven, CT).

Professor Luigi Solbiati (IT),InterventionalRadiologist, pioneer of percutaneous liver ablation techniques, Professor ofRadiology at Humanitas University (Rozzano - Milan), joins Professor GuyVallancien (FR), urology surgeon, and pioneer of laparoscopic and roboticsurgery, as honorary member of this Scientific Advisory Board.

Quantum Surgical is actively preparing to launch inEurope Epione®, a unique robotic platform designed to assist the physician inperforming safer and more efficient percutaneous thermal ablations in the liver(a minimally invasive treatment in which a needle is inserted through the skinto the malignancies to burn them).

We are honored anddelighted to expand our SAB with the appointment of Professor Thierry de Baere,who took part in our first clinical study in which 21 patients were successfullytreated in France,” declaresBertin Nahum, CEO, and co-founder of Quantum Surgical. “We will continue to benefitfrom precious advice provided by these internationally renowned physicians todevelop clinical adoption in the European and American markets.

The future of minimally invasive cancer treatment is today.